SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 261.79
( 0.34%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,673.34 20.47
(0.19%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

108.9247686

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

54.72

5368.04

EPS(TTM)

Face Value()

Div & Yield %

9.25

0.1

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	729.81	667.20	605.46	598.34	636.36	465.51
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	729.81	667.20	605.46	598.34	636.36	465.51
Other Income	43.72	36.22	33.50	50.77	35.37	17.68
Stock Adjustments	25.62	-6.63	6.36	-21.24	8.90	8.85
Total Income	799.15	696.79	645.32	627.87	680.63	492.04
EXPENDITURE :
Raw Materials	368.25	339.47	305.83	293.66	352.84	262.15
Power & Fuel Cost	12.95	9.76	8.81	5.80	7.09	6.99
Employee Cost	121.50	99.42	82.59	72.54	65.06	58.61
Other Manufacturing Expenses	20.05	15.50	17.25	11.57	11.54	7.49
Selling & Administrative Expenses	79.30	78.23	66.73	66.90	67.07	36.90
Miscellaneous Expenses	21.50	26.61	64.52	36.48	32.45	10.76
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	623.54	568.98	545.74	486.95	536.05	382.90
Operating Profit	175.59	127.80	99.59	140.93	144.57	109.14
Interest	11.11	6.58	5.81	10.06	4.32	4.19
Gross Profit	164.48	121.22	93.78	130.87	140.25	104.95
Depreciation	31.02	27.05	23.52	15.17	13.85	13.76
Profit Before Tax	133.46	94.17	70.26	115.70	126.40	91.19
Tax	42.54	29.99	26.34	34.42	31.92	21.52
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.95	-4.79	-6.72	-4.21	1.81	2.16
Reported Net Profit	96.87	68.97	50.64	85.48	92.66	67.50
Extraordinary Items	-1.25	-0.14	-25.47	0.26	2.09	-0.02
Adjusted Net Profit	98.12	69.11	76.11	85.22	90.57	67.52
Adjustment below Net Profit	-0.18	-0.56	-0.15	-0.67	0.30	0.52
P & L Balance brought forward	956.86	892.57	846.18	765.33	676.22	613.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	9.91	4.12	4.10	3.97	3.86	5.16
P & L Balance carried down	1043.65	956.86	892.57	846.18	765.33	676.22
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	50.00	50.00	50.00	50.00	50.00	50.00
Dividend Per Share(Rs)	0.50	0.50	0.50	0.50	0.50	0.50
Earnings Per Share-Unit Curr	9.16	6.55	4.84	8.21	8.94	6.54
Earnings Per Share(Adj)-Unit Curr	9.16	6.55	4.84	8.21	8.94	6.54
Book Value-Unit Curr	109.20	100.47	94.41	89.96	82.12	73.26
Book Value(Adj)-Unit Curr	109.20	100.47	94.41	89.96	82.12	73.26

77,763.91 261.79 ( 0.34%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,733.68 1,000.53 (1.46%)

10,673.34 20.47 (0.19%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)